Physician profile
Katherine White
NPI 1831700442
$4,775.51
in general payments reported to CMS, 2019-2025
17 companies · $1,980 in 2025
The $1,980 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.83 · 2022: $666 · 2023: $789 · 2024: $1,278 · 2025: $1,980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,963 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,963.05 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $922.78 | 2022-2025 | Trulance, Relistor |
| Genzyme Corporation | $679.30 | 2023-2025 | |
| Janssen Biotech, INC. | $649.01 | 2024-2025 | Tremfya, Stelara |
| Lilly USA, LLC | $400.20 | 2024-2025 | Omvoh |
| Pfizer INC. | $302.36 | 2024-2025 | |
| Ardelyx, INC. | $295.53 | 2023-2025 | Ibsrela |
| Madrigal Pharmaceuticals | $266.72 | 2024-2025 | Rezdiffra, Resmetirom |
| Celgene Corporation | $240.71 | 2022-2023 | Zeposia |
| Merck Sharp & Dohme LLC | $231.23 | 2021-2024 | Dificid |
| Ironwood Pharmaceuticals, INC | $225.22 | 2023-2024 | Linzess |
| Regeneron Healthcare Solutions, INC. | $190.11 | 2024-2025 | Dupixent |
| Abbvie INC. | $110.80 | 2022-2025 | |
| Braintree Laboratories, INC. | $106.83 | 2023-2025 | Suflave, Sutab |
| Takeda Pharmaceuticals U.S.A., INC. | $66.30 | 2021-2022 | |
| Exact Sciences Corporation | $34.89 | 2024 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $31.73 | 2021 | |
| Gilead Sciences, INC. | $21.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.